Health
Indivior Plunges as Drugmaker Warns of Falling Revenue, Profit
A box of Indivior's Suboxone medication.
Photographer: George Frey/Bloomberg
This article is for subscribers only.
Indivior Plc shares tumbled after the drugmaker warned of declining revenue and profit this year, amid competition for its opioid addiction medicines.
Revenue could fall almost 20% this year and operating profit as much as 41%, the UK company said in a statement Thursday.